Which method is superior in predicting the severity and extent of coronary artery disease:Metabolic syndrome NCEP-ATP III criteria or MS score?

Objective & Hypothesis:Objectives: Definition of metabolic syndrome (MS) was made according to the NCEP-ATP III criteria and the new MS scoring system developed by Macchia et al., and the role of each method was assessed in predicting the severity and extent of coronary artery disease (CAD).

📊

Key Findings & Data:Study design: The study included 158 patients (103 males, 55 females) who underwent coronary angiography for CAD.

💡

Conclusion & Impact:Patients were classified as having severe (≥20, n=69) or mild (

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Objectives: Definition of metabolic syndrome (MS) was made according to the NCEP-ATP III criteria and the new MS scoring system developed by Macchia et al., and the role of each method was assessed in predicting the severity and extent of coronary artery disease (CAD). Study design: The study included 158 patients (103 males, 55 females) who underwent coronary angiography for CAD. Metabolic syndrome was identified according to both the NCEP-ATP III criteria and the MS score. MS scores were calculated by summing all the points rated for sex, age, body mass index, hypertension, and levels of HDL-cholesterol, triglyceride, and fasting glucose. The severity and extent of CAD were evaluated by the Gensini score. Patients were classified as having severe (≥20, n=69) or mild (

Özet

Amaç: Metabolik sendrom (MS), NCEP-ATP III ve Macchia ve ark. tarafından geliştirilen MS skorlama yöntemine göre iki farklı biçimde tanımlandı ve bu iki yöntemin koroner arter hastalığı (KAH) ciddiyeti ve yaygınlığını belirlemedeki etkinliği incelendi. Çalışma planı: Çalışmaya KAH nedeniyle koroner anjiyografi yapılan ardışık 158 hasta (103 erkek, 55 kadın) alındı. Metabolik sendrom, hem NCEP-ATP III'e, hem de MS skoruna göre değerlendirildi. MS skorlaması, yaş, cinsiyet, beden kütle indeksi, hipertansiyon, HDL-kolesterol, trigliserid ve glukoz düzeylerine göre belirtilmiş olan puanların her bir hasta için ayrı ayrı toplanmasıyla hesaplandı. Koroner arter hastalığı ciddiyeti ve yaygınlığı Gensini puanlamasına göre değerlendirildi. Hastalar önce Gensini skoruna göre ciddi KAH (≥20, n=69) ve hafif KAH (

🔖

Cite This Article

DEĞİRMENCİOĞLU, A., ÖZER, N., KAŞIKÇIOĞLU, H., TANGÜREK, B., ÖZAL, E., AKKAYA, E., UYAREL, H., ÖZTÜRK, R., ÇAM, N., ORHAN, G., TARTAN, Z. (2022). Which method is superior in predicting the severity and extent of coronary artery disease:Metabolic syndrome NCEP-ATP III criteria or MS score?. Türk Kardiyoloji Derneği Arşivi, Cilt: 35 - Sayı: 3, 170–176. https://ajindex.com/articles/633618

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. 2.Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9. 3.Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996;45:633-8. 4.National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143 421. 5.Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53. 6.Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi R, et al. A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (GISSI)-Prevenzione scoring. Am Heart J 2006; 151:754.e7-754.e17. 7.Onat A, Sansoy V. Metabolic syndrome, major culprit of coronary disease among Turks: its prevalence and impact on coronary risk. [Article in Turkish] Türk Kardiyol Dern Arş 2002;30:8-15. 8.Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502. 9.Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. 10.Oishi Y, Wakatsuki T, Nishikado A, Oki T, Ito S. Circulating adhesion molecules and severity of coronary atherosclerosis. Coron Artery Dis 2000;11:77-81. 11.Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003;26:3153-9. 12.Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the “metabolic syndrome” and incidence of type 2 diabetes. Diabetes 2002;51:3120-7